NEWS & INSIGHTS

Latest News
Exscientia appoints Dr. David Hallett as Chief Operating Officer as company positions for further growth
Read Now

All

Exscientia appoints Dr. David Hallett as Chief Operating Officer as company positions for further growth

READ MORE

Bayer and Exscientia collaborate to leverage the potential of artificial intelligence in cardiovascular and oncology drug discovery

READ MORE

Sanofi Exercises option on Exscientia-designed bispecific small molecule for treatment of immunological conditions

READ MORE

Exscientia enters broad rare disease drug discovery collaboration with Rallybio

READ MORE

Exscientia expands international collaborations with Shanghai-headquartered GT Apeiron Therapeutics

READ MORE

Exscientia achieves molecule discovery milestone as part of GSK collaboration

READ MORE

Exscientia continues expansion with establishment of a subsidiary in Japan to target the pharmaceutical market across Asia

READ MORE

Exscientia がアジアの創薬マーケットを狙った子会社を日本に設立

READ MORE

Celgene and Exscientia enter 3-year AI drug discovery collaboration focused on accelerating drug discovery in oncology and autoimmunity

READ MORE
  • <<
  • 1
  • 2
  • 3
  • 4
  • 5
  • >>